Cancer Gene Therapy
Gene transfer and therapeutic effect increased by adenovirus intrahepatic injection
Published in Cancer Weekly, October 31st, 2006
"Recombinant Ads are among the most extensively used vectors for liver gene transfer. One of the major limitations for the clinical application of these vectors is the inflammatory immune response associated with systemic administration of high dose of virus.
"We evaluated the effect of Ad administration route on the inflammatory immune response and liver transgene expression. We compared direct intrahepatic injection (IH) with the systemic administration via tail vein (IV),"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-10-31)
More Articles from Cancer Weekly
- Bladder Cancer
Risk of bladder cancer recurrence after radical cystectomy predicted by postoperative nomogram - Esophageal Cancer
Esophageal adenocarcinoma risk linked to XPD 751Gln allele - Osteosarcoma
Primary osteosarcoma in patients older than 40 years of age related to poorer prognosis - Prostate Cancer
Prostate cancer risk lowered by dietary isoflavones due to gut-formed isoflavone metabolites - Cancer Gene Therapy
Chinese University of Hong Kong, Department of Surgery publishes research in cancer gene therapy - Cancer Gene Therapy
Data on cancer gene therapy described by researchers at Huazhong University of Science and Technology, Department of Immunology - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
